<p>Estimated 12-month prevalences as a function of location, method, and level of competition motivation.</p
<p>Prevalence of 12-month treatment among those with personality disorders in the Sao Paulo Metropol...
<p>Factor associated with 12-month prevalence of WMSDs in the different body region by age, BMI, job...
12-month prevalence rate of schizophrenia, schizotypal and delusional disorders, 2008–2017.</p
<p>12-month prevalences for the use of legal and freely available substances.</p
<p>Inferred prevalence rates of risk increasing behaviours among the public (n = 926).</p
<p>Estimated 12-month prevalences for physical and cognitive doping using the UQM for <i>p</i> ≈ 1/3...
<p>The correlation between HIV-2 prevalence and estimated MC rate for different subsets of cities.</...
<p>HIV/STI incidence density over 12 months: Overall, by intervention group and site.</p
<p>Prevalence of demographic and lifestyle characteristics according to physical activity level.</p
<p>Estimates of the annual force of infection (λ) and seroreversion (r) by country.</p
<p>Malariometric parameters Prevalence by Age Group in active surveillance cohort according to the s...
<p>Prevalence of Hepatitis C antibodies by number of medical injections received in the last 6 month...
<p>Country-weighted regional mean prevalence estimates by prevalence measure and by population age (...
<p>Prevalence and duration of holidays abroad (in the 3 months prior to each visit) according to sea...
<p>The overall 12-month prevalence in all the MDD patients and subgroups by gender.</p
<p>Prevalence of 12-month treatment among those with personality disorders in the Sao Paulo Metropol...
<p>Factor associated with 12-month prevalence of WMSDs in the different body region by age, BMI, job...
12-month prevalence rate of schizophrenia, schizotypal and delusional disorders, 2008–2017.</p
<p>12-month prevalences for the use of legal and freely available substances.</p
<p>Inferred prevalence rates of risk increasing behaviours among the public (n = 926).</p
<p>Estimated 12-month prevalences for physical and cognitive doping using the UQM for <i>p</i> ≈ 1/3...
<p>The correlation between HIV-2 prevalence and estimated MC rate for different subsets of cities.</...
<p>HIV/STI incidence density over 12 months: Overall, by intervention group and site.</p
<p>Prevalence of demographic and lifestyle characteristics according to physical activity level.</p
<p>Estimates of the annual force of infection (λ) and seroreversion (r) by country.</p
<p>Malariometric parameters Prevalence by Age Group in active surveillance cohort according to the s...
<p>Prevalence of Hepatitis C antibodies by number of medical injections received in the last 6 month...
<p>Country-weighted regional mean prevalence estimates by prevalence measure and by population age (...
<p>Prevalence and duration of holidays abroad (in the 3 months prior to each visit) according to sea...
<p>The overall 12-month prevalence in all the MDD patients and subgroups by gender.</p
<p>Prevalence of 12-month treatment among those with personality disorders in the Sao Paulo Metropol...
<p>Factor associated with 12-month prevalence of WMSDs in the different body region by age, BMI, job...
12-month prevalence rate of schizophrenia, schizotypal and delusional disorders, 2008–2017.</p
DOI
Add to ORKG